Başak Oyan

547 total citations
39 papers, 348 citations indexed

About

Başak Oyan is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Başak Oyan has authored 39 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Başak Oyan's work include Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Başak Oyan is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Viral-associated cancers and disorders (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Başak Oyan collaborates with scholars based in Türkiye, United Kingdom and Romania. Başak Oyan's co-authors include Susan Dent, A Hönig, Mehmet Akif Öztürk, Sacha J. Howell, Max S. Mano, Emin Kansu, Alev Türker, Yener Koç, Şuayib Yalçın and Meltem Halil and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Treatment Reviews and Psycho-Oncology.

In The Last Decade

Başak Oyan

35 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Başak Oyan Türkiye 12 155 92 68 54 45 39 348
Timuçin Çil Türkiye 14 111 0.7× 119 1.3× 46 0.7× 47 0.9× 65 1.4× 62 462
N. Eche France 11 113 0.7× 61 0.7× 71 1.0× 63 1.2× 55 1.2× 25 361
Junichi Tomomatsu Japan 13 232 1.5× 158 1.7× 106 1.6× 61 1.1× 48 1.1× 49 431
Mohammed A. Osman Egypt 12 166 1.1× 69 0.8× 66 1.0× 41 0.8× 19 0.4× 25 404
Özlem Erçelep Türkiye 12 175 1.1× 145 1.6× 64 0.9× 72 1.3× 27 0.6× 55 366
Mustafa Yaylacı Türkiye 10 187 1.2× 49 0.5× 49 0.7× 30 0.6× 48 1.1× 28 413
Anna Roma Italy 12 161 1.0× 128 1.4× 102 1.5× 57 1.1× 21 0.5× 28 370
Manali Bhave United States 10 160 1.0× 115 1.3× 67 1.0× 108 2.0× 31 0.7× 46 523
Tetsuya Urasaki Japan 12 205 1.3× 107 1.2× 73 1.1× 99 1.8× 26 0.6× 53 416
Salma Alam United Kingdom 10 143 0.9× 160 1.7× 91 1.3× 53 1.0× 35 0.8× 14 332

Countries citing papers authored by Başak Oyan

Since Specialization
Citations

This map shows the geographic impact of Başak Oyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Başak Oyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Başak Oyan more than expected).

Fields of papers citing papers by Başak Oyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Başak Oyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Başak Oyan. The network helps show where Başak Oyan may publish in the future.

Co-authorship network of co-authors of Başak Oyan

This figure shows the co-authorship network connecting the top 25 collaborators of Başak Oyan. A scholar is included among the top collaborators of Başak Oyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Başak Oyan. Başak Oyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başaran, Gül, Erhan Gökmen, Nil Molinas Mandel, et al.. (2024). Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases.. Journal of Clinical Oncology. 42(16_suppl). 545–545.
2.
Akyürek, Nalân, Adnan Aydıner, Recep Savaş, et al.. (2023). Immunotherapy for Lung Cancer. AYBU AVESIS. 9(2). 97–111.
3.
4.
Rordorf, Tamara, Ibrahim A. Hassan, Hamdy A. Azim, et al.. (2014). Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup. The Breast. 23(5). 511–525. 14 indexed citations
5.
Dent, Susan, Başak Oyan, A Hönig, Max S. Mano, & Sacha J. Howell. (2013). HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treatment Reviews. 39(6). 622–631. 66 indexed citations
6.
Ordu, Çetın, et al.. (2013). Development of Acute Pulmonary Hypertension After Bortezomib Treatment in a Patient With Multiple Myeloma. American Journal of Therapeutics. 22(3). e88–e92. 12 indexed citations
7.
Öztürk, Mehmet Akif, et al.. (2013). Pituitary Metastasis of Colon Adenocarcinoma: A Rare Occurrence. Journal of Gastrointestinal Cancer. 45(S1). 85–87. 5 indexed citations
8.
Oyan, Başak. (2012). Why do targeted agents not work in the adjuvant setting in colon cancer?. Expert Review of Anticancer Therapy. 12(10). 1337–1345. 10 indexed citations
9.
Öztürk, Mehmet Akif, et al.. (2012). Takotsubo syndrome. Blood Coagulation & Fibrinolysis. 24(1). 90–94. 29 indexed citations
10.
11.
Ordu, Çetın, et al.. (2011). The prognostic relevance of response evaluation to chemotherapy by FDG-PET/CT in patients with metastatic non-small cell lung cancer.. Journal of Clinical Oncology. 29(15_suppl). e18055–e18055.
12.
Oyan, Başak. (2011). Potential role of bone-directed therapy on the superiority of aromatase inhibitors over tamoxifen. Medical Hypotheses. 77(6). 1028–1030. 1 indexed citations
13.
14.
Oyan, Başak, Yener Koç, Ayşe Kars, et al.. (2005). IIVP Salvage Regimen Induces High Response Rates in Patients With Relapsed Lymphoma Before Autologous Stem Cell Transplantation. American Journal of Clinical Oncology. 28(3). 264–269. 6 indexed citations
15.
Oyan, Başak, Yener Koç, Evren Özdemir, et al.. (2005). Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 11(9). 688–697. 11 indexed citations
16.
17.
Koç, Yener, Başak Oyan, Ayşe Kars, et al.. (2004). A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. Hematological Oncology. 22(2). 43–53. 4 indexed citations
18.
Altundağ, Kadri, Oğuz Dikbaş, Başak Oyan, Alp Usubutün, & Alev Türker. (2004). Epithelioid Sarcoma of Vulva: A Case Report and Review of the Literature. Medical Oncology. 21(4). 367–372. 21 indexed citations
19.
Cankurtaran, Mustafa, et al.. (2004). Idiopathic fibrosclerosis of bilateral orbits, bilateral ureters, thyroid: A case report and review of the literature. International Urology and Nephrology. 36(4). 495–498. 3 indexed citations
20.
Oyan, Başak, Hüseyin Engin, & Şuayib Yalçın. (2002). Generalized Lymphadenopathy: A Rare Presentation of Disseminated Prostate Cancer. Medical Oncology. 19(3). 177–180. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timuçin Çil Breakdown of academic impact, for papers by N. Eche Breakdown of academic impact, for papers by Junichi Tomomatsu Breakdown of academic impact, for papers by Mohammed A. Osman Breakdown of academic impact, for papers by Özlem Erçelep Breakdown of academic impact, for papers by Mustafa Yaylacı Breakdown of academic impact, for papers by Anna Roma Breakdown of academic impact, for papers by Manali Bhave Breakdown of academic impact, for papers by Tetsuya Urasaki Breakdown of academic impact, for papers by Salma Alam
Rankless by CCL
2026